CatalystPit

RZLTRezolute, Inc.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $4.14 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$398.65M
CountryUSA
RECENT INSIDER TRADES
  • 2026-07-07 · Evans Daron (CFO) · OTHER
  • 2026-07-07 · ROBERTS BRIAN KENNETH (Chief Medical Officer) · OTHER
  • 2026-07-07 · Elam Nevan C (CEO) · OTHER
  • 2026-03-31 · Evans Daron (CFO) · BUY
  • 2026-03-04 · ROBERTS BRIAN KENNETH (Chief Medical Officer) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders151
Shares held93,561,496
Value$470.83M
Percent of shares outstanding97.16%
As of quarter end2026-06-30
RECENT NEWS
  • Cantor upgrades Rezolute ahead of ersodetug pre-BLA meeting
  • Citizens raises Rezolute price target on FDA feedback
  • Rezolute Announces FDA Recommendation to Hold a Pre-BLA Meeting as a Precursor to Submitting a Biologics License Application (BLA) for Congenital Hyperinsulinism
  • Citizens reiterates Rezolute stock rating on tumor trial results due
  • Rezolute reports GAAP EPS of -$0.20, missing estimate by $0.05
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS